In addition, inhibition of p38-MAPK activity can revert the loss of synaptophysin induced by IL-1β in rat primary cortical neuronal cultures and in an animal model of Alzheimer’s disease [25, 58, 59]. This evidence concerns the gene MAPK14 and Alzheimer disease.